Mean ( standard deviation [ SD ] ) anti-Xa activity at 3h post-dose was approximately 60 % higher following co-administration compared with apixaban alone , 4.4 [ 1.0 ] vs. 2.7 [ 0.7 ] IUml ( -1 ) , consistent with the apixaban concentration increase following co-administration .